KATHRYN THOMPSON: Open Payments
NPI 1558529255 · SHELTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,564 in 113 payments from 21 companies in 2025. Trend: 2023 $2,871 · 2024 $2,911 · 2025 $2,564
Food & beverage: $2,564
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $294 |
| GENZYME CORPORATION | 9 | $266 |
| Incyte Corporation | 10 | $245 |
| ABBVIE INC. | 13 | $206 |
| Lilly USA, LLC | 9 | $202 |
| Regeneron Healthcare Solutions, Inc. | 9 | $181 |
| Organon LLC | 7 | $175 |
| UCB, Inc. | 5 | $174 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 7 | $131 |
| E.R. Squibb & Sons, L.L.C. | 4 | $102 |
Products named: DUPIXENT, TREMFYA, OPZELURA, Bimzelx, SKYRIZI, Cabtreo, TALTZ, Sotyktu.
Industry payments across CT — which companies pay providers there.
